Aarti Pharmalabs Reports Strong Q2 FY27 Results and Appoints New CFO
Aarti Pharmalabs Ltd 路 Change in Management 路 29 Oct 2026, 2:34 am
Aarti Pharmalabs Reports Strong Q2 FY27 Results and Appoints New CFO Aarti Pharmalabs reported consolidated Q2 revenue from operations of Rs 61,045.10 lakhs for the quarter ended 30th Sep'26, up 45.9% YoY from Rs 41,833.48 lakhs. Consolidated net profit surged 248.8% YoY to Rs 7,147.23 lakhs compared to Rs 2,049.27 lakhs in Q2 FY26. Diluted EPS rose to Rs 7.87 from Rs 2.26. The board recognized an exceptional provision of Rs 204.00 lakhs regarding a disputed Gujarat stamp duty order. Additionally, Smt. Vibha Thakkar was appointed CFO, effective 31st Oct'26, succeeding Shri Piyush Lakhani.
Original exchange filing (PDF)
More announcements from Aarti Pharmalabs Ltd
- Intimation of sad demise of Promoter and Chairman Emeritus of the Company 路 16 Nov 2026
- Q2 FY 27 Earnings Call Transcript 路 04 Nov 2026
- Audio Recording of Conference Call for Investor and Analysts 路 30 Oct 2026
- Q2 FY 2027 Investor Presentation 路 29 Oct 2026
- Please find enclosed 路 29 Oct 2026
- Please find enclosed 路 29 Oct 2026
- Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
- Please find enclosed 路 29 Oct 2026
